Clinical trial

A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of…

NCT00182260 · McMaster University, Other · Completed

Key facts

NCT number NCT00182260
Title A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD
Official title ELVIS (Esophagitis-Laparoscopy Versus Inhibitors of Secretion) A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication (LNF) Versus Omeprazole for Treatment of Patients With Chronic Gastro-Esophageal Reflux Disease (GERD)
Lead sponsor McMaster University, Other
Collaborators St. Joseph's Healthcare Hamilton
Status Completed
Study type Interventional
Conditions Gastroesophageal Reflux
Intervention type Drug, Procedure
Interventions Proton Pump Inhibitors, Laparoscopic Nissen Fundoplication
Enrollment 216
Start date Jan 1, 2000
Primary completion Apr 1, 2010
Completion Apr 1, 2010
First posted Sep 16, 2005
Last update posted Nov 15, 2012
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies